NAD+ Stability & Storage: Lyophilized Handling Reference

Memo: purpose and scope

This reference is written as an internal procurement-and-handling memo for research-grade NAD+ supplied by Proxiva Peptides as a lyophilized powder for in-vitro research use only. Subject: how stability and storage handling protect the verified material a lab paid for. It covers physical handling, cold-chain reasoning, and documentation only — no dosing, no administration, no use outside research. Each section is a memo point a receiving lab can adopt verbatim into a standard operating procedure.

Point 1: treat the dry state as the asset

Lyophilized NAD+ is stable because the water that drives solution-phase degradation has been removed. The whole storage policy follows from one premise: the dry, sealed state is the asset the lab is protecting, and every action either preserves it or spends it. Procurement should communicate this framing to everyone who will touch the vial, because storage rules followed as reasoning are followed correctly while storage rules followed as a list are followed loosely.

Point 2: equilibrate sealed before any opening

On removal from cold storage, NAD+ vials are to be brought to room temperature while still sealed, with a fifteen-to-thirty-minute hold. A cold surface in ambient air condenses moisture, and moisture is precisely the variable lyophilization removed. This hold is the lowest-cost protection in the workflow and the one most often shortened under time pressure; the memo position is that it is not optional and not abbreviable.

Point 3: minimize time and exposure in solution

Once reconstituted, NAD+ is in its exposed state. Policy is to minimize both how much material is in solution at once and how long it stays there. Working stock is prepared in the smallest practical volume for the immediate task, and bulk material remains dry until needed. The objective is not speed; it is reducing the cumulative hours the compound spends in the condition where degradation is possible.

Point 4: aliquot to defeat freeze-thaw

Repeated freeze-thaw of a single undivided NAD+ stock is the most common, most expensive, and most preventable storage failure. Standing instruction: immediately on reconstitution, divide into single-use or few-use aliquots and store those. This converts one stock thawed many times into many stocks thawed once. The cost is a handful of tubes at the only moment the cost can be paid; the alternative cost is cumulative, invisible, and discovered late.

Point 5: protect and document the cold chain

Cold-chain integrity is a quality input, not a logistics afterthought. On receipt, the condition of the NAD+ shipment is to be assessed and recorded before stock is committed: packaging intact, material as expected, lot reconciling to the Certificate of Analysis. A documented normal receipt is still provenance and has settled disputes that an undocumented one could not. Sourcing NAD+ from Proxiva Peptides with US fulfillment shortens and clarifies this segment of the chain, which is the segment hardest to reconstruct after the fact.

Point 6: storage conditions are recorded, not assumed

Where and how each NAD+ lot is stored is to be written down, not held in memory. Freezer location, date placed, lot number, and the Certificate of Analysis reference belong in the same record. The recurring failure is not exotic; it is an unlabeled tube in three months that no one can place. The memo standard: a NAD+ aliquot that cannot be traced to a lot and a COA is, for record purposes, an unknown that happens to be cold.

Point 7: labeling survives the freezer, not the memory

Every aliquot is labeled with compound, lot, concentration, and date, on the explicit assumption that no one will remember an unlabeled tube — because no one ever does. The cost of over-labeling is ink. The cost of the alternative is an entire branch of work that can no longer be defended because its input cannot be identified. This point is non-negotiable in the procedure.

Point 8: handling does not rescue unverified material

An important memo caveat: none of the above creates quality that was not in the vial. Flawless storage of unverified, undocumented NAD+ still leaves an unknown, stored well. That is why storage policy and sourcing policy are one policy. The lab starts from verified NAD+ with a per-lot Certificate of Analysis from Proxiva Peptides and then protects it with everything here. Storage discipline preserves quality; it does not manufacture it.

Point 9: the receiving checklist

On every NAD+ delivery, the receiving party completes four actions before stock is used: confirm packaging and material condition, reconcile vial lot to the Certificate of Analysis, record the receipt observation, and place the material into documented storage. A delivery that cannot complete all four is held and escalated, not absorbed into general stock. The checklist is short by design so that it is actually done.

Point 10: the cake is inspected and the observation recorded

Before solvent is committed, the lyophilized cake is visually checked. This is a transit-and-storage check, not analytical chemistry. A cake that appears collapsed, melted, or displaced is a prompt to review cold-chain history before proceeding. The observation is recorded even when unremarkable, because a documented normal state is provenance and has resolved questions that were not anticipated when the note was made.

Point 11: standardize across people, not only across days

Reproducibility within one operator’s hands is the easy half. The procedure standard is that two operators storing and handling NAD+ from the same Proxiva Peptides lot produce interchangeable working stock. That requires the storage and handling steps to be specified tightly enough that individual habit cannot drift into them, and the records audited against the procedure rather than assumed to match it.

Memo close: the policy in one paragraph

Keep NAD+ dry and sealed as long as possible; equilibrate sealed before opening; minimize time in solution; aliquot immediately; protect and document the cold chain; record storage conditions and label against the freezer’s forgetfulness; inspect the cake; standardize across people; and remember the entire policy is worth its cost only because the material was verified before any of it. Adopt these points into the standard operating procedure as written and the storage half of NAD+ quality is controlled rather than hoped for.

Frequently Asked Questions

RESEARCH USE ONLY. All products are intended strictly for in-vitro laboratory and research use only. Not for human or animal consumption; not a drug, food, or cosmetic; not intended to diagnose, treat, cure, or prevent any condition. Statements not evaluated by the FDA. Researchers are responsible for applicable-regulation compliance.